...
机译:可变肾功能患者万长霉素的新人口药代动力学模型:基于CKD-EPI估算的扩展协变量模型的治疗药物监测
Department of Pharmacology and PharmacoGenomics Research CenterInje University College of;
Hallym Institute for Clinical MedicineHallym University Medical CenterAnyang 14068 Korea;
Department of Pharmacology and PharmacoGenomics Research CenterInje University College of;
Department of Pharmacology and PharmacoGenomics Research CenterInje University College of;
Department of InfectionInje University Haeundae Paik HospitalBusan 48108 Korea;
Department of PharmacologyCatholic Kwandong University College of MedicineGangneung 25601 Korea;
Department of Pharmacology and PharmacoGenomics Research CenterInje University College of;
population pharmacokinetics; therapeutic drug monitoring; vancomycin;
机译:可变肾功能患者万长霉素的新人口药代动力学模型:基于CKD-EPI估算的扩展协变量模型的治疗药物监测
机译:基于两种不同的肾功能标记的神经外科患者血清霉素人口药代理模型的发展与比较
机译:基于来自小儿癫痫患者的稀疏治疗监测数据,开发卡马西平的总体药代动力学模型。
机译:肽受体放射性核素治疗治疗计划的生理基于药代动力学模型的人口与协变化模型研究
机译:临床药代动力学模拟/建模,作为特殊患者人群中治疗药物监测和剂量调整的工具。
机译:特殊患者亚群中的万古霉素治疗药物监测和群体药代动力学模型
机译:Vancomycin治疗药物监测和群体药代动力学模型在特殊患者群体中